Key result
Novel biomarkers, such as high-sensitivity troponin T, show promise in improving cardiovascular disease risk prediction in women, though many remain incompletely studied.
Why the study?
Do novel biomarkers improve cardiovascular disease risk prediction in women compared to traditional algorithms?
Population
Women at risk of cardiovascular disease
Comparison
Novel biomarkers for risk prediction vs Traditional risk prediction algorithms
Design
Review
Authors
Loading...
May refine CVD risk prediction in women; leaves open the need for prospective validation with greater female inclusion.
Do novel biomarkers improve cardiovascular disease risk prediction in women compared to traditional algorithms?
Novel biomarkers like high-sensitivity troponin T show promise in improving cardiovascular disease risk prediction in women, highlighting the need for increased inclusion of women in future biomarker studies.
Paynter et al. (2013) conducted a review in Cardiovascular disease. Novel biomarkers was evaluated on Cardiovascular disease risk prediction. Novel biomarkers, such as high-sensitivity troponin T, show promise in improving cardiovascular disease risk prediction in women, though many remain incompletely studied.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: